IPO Year: 2021
Exchange: NYSE
| Date | Price Target | Rating | Analyst |
|---|
8-K - FOXO TECHNOLOGIES INC. (0001812360) (Filer)
D - FOXO TECHNOLOGIES INC. (0001812360) (Filer)
424B3 - FOXO TECHNOLOGIES INC. (0001812360) (Filer)
424B3 - FOXO TECHNOLOGIES INC. (0001812360) (Filer)
424B3 - FOXO TECHNOLOGIES INC. (0001812360) (Filer)
8-K - FOXO TECHNOLOGIES INC. (0001812360) (Filer)
8-K - FOXO TECHNOLOGIES INC. (0001812360) (Filer)
424B3 - FOXO TECHNOLOGIES INC. (0001812360) (Filer)
424B3 - FOXO TECHNOLOGIES INC. (0001812360) (Filer)
424B3 - FOXO TECHNOLOGIES INC. (0001812360) (Filer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)
4 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)
3 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)
3 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)
3 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)
4 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)
4 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)
4/A - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)
4/A - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)
4 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)
Fastest customizable press release news feed in the world
FOXO Commences its Inaugural Managing General Agency ("MGA") Relationship with a Full Suite of Life Insurance Products Bundled with the FOXO Longevity Report™ FOXO Technologies Inc. to Trade on the NYSE American Under the Ticker Symbols "FOXO" Beginning Friday, September 16th FOXO Technologies Inc. ("FOXO" or the "Company"), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced the completion of its business combination (the "Business Combination") with Delwinds Insurance Acquisition Corp. (NYSE:DWIN) ("Delwinds"), a publicly traded special purpose
Houston, TX, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Delwinds Insurance Acquisition Corp. ("DWIN" or the "Company") (NYSE:DWIN), a publicly traded special purpose acquisition company, announced today that it has entered into a Forward Share Purchase Agreement (the "Purchase Agreement") with Meteora Capital Partners or its affiliates (collectively, "Meteora") pursuant to which Meteora (i) has committed to owning, as of the date (the "BC Closing Date") of consummation of DWIN's previously announced business combination with FOXO Technologies Inc. (the "Business Combination" and "FOXO"), a certain number of shares of DWIN Class A common stock ("Public Shares"), and (ii) may purchase up to an addit
Houston, TX, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Delwinds Insurance Acquisition Corp. ("DWIN" or the "Company") (NYSE:DWIN), a publicly traded special purpose acquisition company, announced today that, as of 5:00 pm Eastern Time on September 12, 2022 (the "Redemption Deadline"), Delwinds has received requests to redeem a total of 10,991,407 DWIN public shares, which requests may be withdrawn at any time prior to the consummation of the previously announced business combination (the "Business Combination") between DWIN and FOXO Technologies Inc. ("FOXO"), or such other date as the Board of Directors of DWIN (the "DWIN Board") may determine to be the deadline for accepting withdrawals of such
Houston, TX, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Delwinds Insurance Acquisition Corp. ("Delwinds") today announced that it will transfer its listing from The New York Stock Exchange (the "NYSE") to the NYSE American LLC ("NYSE American"). In connection with listing on NYSE American, Delwinds will voluntarily delist from the NYSE. Following the transfer of listing, Delwinds will continue to file the same types of periodic reports and other information it currently files with the Securities and Exchange Commission (the "SEC"). Following the expected consummation of the previously announced business combination (the "Business Combination") between Delwinds and FOXO Technologies Inc. ("FOXO")
Houston, TX, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Delwinds Insurance Acquisition Corp. ("DWIN" or the "Company") (NYSE:DWIN), a publicly traded special purpose acquisition company, announced today that DWIN anticipates entering into an arrangement whereby an institutional investor and its affiliates (collectively, the "Investor") (i) would commit to own, as of the date (the "Business Combination Closing") of consummation of Delwinds' previously announced business combination with FOXO Technologies Inc. (the "Business Combination" and "FOXO"), a certain number of shares of Delwinds Class A common stock ("Public Shares"), and (ii) may purchase up to an additional number of Public Shares fro
Houston, TX, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Delwinds Insurance Acquisition Corporation ("DWIN") (NYSE:DWIN), a publicly traded special purpose acquisition company, and FOXO Technologies, Inc. ("FOXO"), a technology company applying epigenetic science and AI to modernize the life insurance industry, announced that DWIN's registration statement on Form S-4 (the "Registration Statement"), relating to the previously announced proposed business combination between DWIN and FOXO (the "Business Combination"), was declared effective by the U.S. Securities and Exchange Commission (the "SEC") on August 26, 2022. DWIN will hold a Special Meeting of Stockholders ("Special Meeting") on September 1
Minneapolis, MN & Houston, TX, June 02, 2022 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. ("FOXO"), a technology company applying epigenetic science and AI to modernize the life insurance industry, which announced earlier this year that it would become a public company via a business combination (the "Transaction") with special purpose acquisition company Delwinds Insurance Acquisition Corp. (NYSE:DWIN), today announced that Founder and Chief Executive Officer Jon Sabes will participate in the following investor conferences in June: Goldman Sachs Insurtech ConferenceAttending: Monday, June 6, 2022Presentation time: 12:30 p.m. Eastern timeWhere: Virtual fireside chat - Webcast link Credit S
FOXO aims to make longevity science fundamental to life insurance FOXO applies epigenetic science and AI to commercialize saliva-based biomarkers that simplify the consumer underwriting journey and enhance the consumer value proposition FOXO plans to launch proprietary life insurance products in 2022 that drive distribution and services platform offering saliva-based underwriting technology and consumer engagement Transaction estimates a pre-money enterprise value of $369 million for FOXO Investor call scheduled for February 25th at 10:00 a.m. ET Minneapolis, MN & Houston, TX, Feb. 24, 2022 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. ("FOXO"), a technol
This live feed shows all institutional transactions in real time.
SC 13D - FOXO TECHNOLOGIES INC. (0001812360) (Subject)
SC 13D/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)
SC 13D/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)
SC 13D - FOXO TECHNOLOGIES INC. (0001812360) (Subject)
SC 13D - FOXO TECHNOLOGIES INC. (0001812360) (Subject)
SC 13G - FOXO TECHNOLOGIES INC. (0001812360) (Subject)
SC 13G/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)
SC 13G - FOXO TECHNOLOGIES INC. (0001812360) (Subject)
SC 13G/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)
SC 13G/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)